HM13 is a predictive biomarker of metastasis and neutrophil infiltration in colorectal cancer.
Year: 2025
Type: article
Abstract: BACKGROUND: High levels of histocompatibility minor 13 (HM13) have been related to the progression of several cancers. Here, we investigated the function of HM13 in colorectal cancer (CRC). METHODS: verification of HM13 function. RESULTS: studies further confirmed that MPO overexpression partially abolished the inhibition of tumor growth by sh-HM13 in CRC. CONCLUSION: The results suggested that high HM13 expression in CRC could promote tumor growth and metastasis by reducing neutrophil infiltration and may serve as a useful target in the treatment of metastatic CRC.
Source: PubMed
DOI: 10.14670/hh-18-857
Authors: Yanbing Ren, Ying Mao, Xiao Yuan
Language: English
Topic: Immune cells in cancer
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W4405658331
